...
机译:拓扑异构酶Ⅱ与白血病
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee;
Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee;
Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania;
Department of Medical and Molecular Genetics, King's College London School of Medicine, London, United Kingdom;
Departments of Biochemistry and Medicine, Vanderbilt University School of Medicine, 654 Robinson Research Building, 2200 Pierce Ave., Biochemistry Department, RRB 654, Nashville, TN 37232-0146,Department of Medicine (Hematology/Oncology), Vanderbilt University School of Medicine, Nashville, Tennessee;
topoisomerase Ⅱ poison; anticancer drug; chromosomal translocation; acute myeloid leukemia; acute promyelocytic leukemia;
机译:急性髓性白血病中的组成型拓扑异构酶I-DNA共价络合物及其治疗靶向的影响。
机译:拓扑异构酶IIα(TOP2α/ 90)的新型C末端截短的90-KDA同种型是通过与TOP2α/ 170同种型的异二聚合的K562白血病细胞中依托泊苷抗性的决定率
机译:急性髓性白血病细胞中泌氰酸的抗肿瘤效应涉及细胞死亡,细胞生长和拓扑异构酶抑制
机译:血液白血病图像中急性白血病细胞彩色图像增强检测样本
机译:拓扑异构酶II抑制剂诱导婴儿白血病中常见的非法基因组重排。
机译:CoII-奎那利嗪的活性:A基于蒽环类抗癌药的新型类似物靶向人类DNA拓扑异构酶奎那利嗪本身通过形成起作用醌对急性淋巴细胞白血病MOLT-4和HCT的影响116细胞
机译:继急性白血病治疗急性白血病酶II基化疗后,副急性髓性白血病和髓细胞育胰岛素没有染色体11q23的异常
机译:基于阿拉巴马大学伯明翰分校的流行病学研究:急性髓性白血病,慢性淋巴细胞白血病和慢性粒细胞白血病,欧盟职业环境中丁二烯暴露的定量风险评估